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Labour is induced in 1 of 5 births
1,2 for
maternal reasons (e.g., preeclampsia,
cardiac or renal disease), fetal reasons
(e.g., intrauterine growth restriction) or a com-
bination (e.g., poorly controlled diabetes,
preterm rupture of the membranes or post-term
pregnancy).3 Induction of labour artificially
ripens the cervix and initiates uterine contrac-
tions in wo men who are not already in labour,
leading to progressive dilation of the cervix to
achieve vaginal birth of a baby at any gestation
beyond the legal definition of fetal viability.4
Although induction of labour has been
 criticized for an associated increased risk of
cesarean delivery, recent studies have shown
that there are fewer cesarean deliveries with
induction than without it. However, the findings
have not had much impact on practice, in part
because the systematic reviews5–8 investigated
subsets of induction and included few ran -
domized controlled trials (RCTs), and because
observational data in a cohort study9 had risk of
confounding. Consumer organizations,10 guide-
lines11 and textbooks12,13 have given contradictory
information about cesarean risk, which can lead
to confusion over decision-making, particularly
given a desire to support normal birth in the
face of increasing cesarean rates worldwide.
Cesarean delivery carries multiple risks to
mother and baby, including maternal death,14
infection and postnatal depression,15,16 and respi-
ratory distress syndrome in neonates.14 Accurate,
precise information about cesarean risk is there-
fore needed for decision-making regarding
labour induction.
We conducted a systematic review and meta-
analysis of RCTs to investigate the risk of ce -
sarean delivery associated with labour induction
compared with expectant management. We also
explored the effects of clinical characteristics
and study quality on the overall result using sub-
group and meta-regression analyses.
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Background: Induction of labour is common,
and cesarean delivery is regarded as its major
complication. We conducted a systematic
review and meta-analysis to investigate
whether the risk of cesarean delivery is higher
or lower following labour induction com-
pared with expectant management.
Methods: We searched 6 electronic databases
for relevant articles published through April
2012 to identify randomized controlled trials
(RCTs) in which labour induction was compared
with placebo or expectant management among
women with a viable singleton pregnancy. We
assessed risk of bias and obtained data on rates
of cesarean delivery. We used regression analy-
sis techniques to explore the effect of patient
characteristics, induction methods and study
quality on risk of cesarean delivery.
Results: We identified 157 eligible RCTs (n =
31 085). Overall, the risk of cesarean delivery
was 12% lower with labour induction than
with expectant management (pooled relative
risk [RR] 0.88, 95% confidence interval [CI]
0.84–0.93; I2 = 0%). The effect was significant
in term and post-term gestations but not in
preterm gestations. Meta-regression analysis
showed that initial cervical score, indication
for induction and method of induction did
not alter the main result. There was a
reduced risk of fetal death (RR 0.50, 95% CI
0.25–0.99; I2 = 0%) and admission to a neona-
tal intensive care unit (RR 0.86, 95% CI 0.79–
0.94), and no impact on maternal death (RR
1.00, 95% CI 0.10–9.57; I2 = 0%) with labour
induction.
Interpretation: The risk of cesarean delivery
was lower among women whose labour was
induced than among those managed expec-
tantly in term and post-term gestations. There
were benefits for the fetus and no increased
risk of maternal death.
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Methods
Data sources and study selection
In April 2012, we searched the electronic data-
bases MEDLINE, Embase, CAB Abstracts,
CENTRAL (the Cochrane Central Register of
Controlled Trials) and Science Citation Index
(accessed via Web of Science) for eligible RCTs
using the search terms and word variants for the
concept “labour induction” and “cesarean deliv-
ery.” The search strategy is outlined in Appendix
1 (available at www.cmaj.ca/lookup/suppl
/doi:10.1503 /cmaj.130925/-/DC1). The Coch -
rane Database of Systematic Reviews was also
searched for primary trials. Titles and abstracts
of all citations were assessed for inclusion by 2
of 3 reviewers (C.M., E.R. or E.M.). Disagree-
ments were resolved through consensus with
input from the third reviewer.
We included RCTs if they recruited pregnant
women carrying a viable fetus, they compared
an active induction with placebo or expectant
management (hereafter referred to as expectant
management), and they reported rates of
cesarean delivery as one of the outcomes.
Methods of active intervention included
mechanical methods (amniotomy, membrane
sweeping, Foley catheter insertion with or with-
out extra-amniotic saline infusion), use of phar-
macologic agents (prostaglandins, oxytocin,
corticosteroids, mifepristone, estrogens, relaxin,
misoprostol, isosorbide mononitrate) and alter-
native methods (acupuncture, breast stimula-
tion, sexual intercourse, homeopathic prepara-
tions, castor oil, bath, enema). We excluded
RCTs that recruited women who had a multiple
pregnancy or were in active labour, those in
which an active intervention was applied in the
control group or within 12 hours after random-
ization and trials in which the control group
comprised women in spontaneous labour. No
restrictions were applied to year, language or
publication status.
Data extraction and quality assessment
Two of us (E.R. and E.M.) independently ex -
tracted the following data from the trials: method
of induction, reason for induction, and number
of cesarean and non cesarean (vaginal or instru-
mental) deliveries in the intervention and control
groups, and information required to assess
methodologic quality. Many of the efficacy or
safety studies did not provide reasons for labour
induction. If primary trials were inaccessible
through online and library databases, we
extracted information from the Cochrane Data-
base of Systematic Reviews and contacted the
authors of the trial to confirm the results.
For the assessment of methodologic quality,
we evaluated the following parameters for risk
of bias: sequence generation, allocation con-
cealment, blinding of participants and person-
nel, and management of incomplete output
data.17 We did not assess blinding of partici-
pants and personnel in trials that used mechani-
cal interventions because it cannot be applied in
such situations.
Disagreements in grouping, coding or quality
assessment were resolved through consensus
with input from a third author (C.M. or K.S.K.).
Data synthesis
We assessed heterogeneity between trials by
inspecting forest plots and using the I2 statistic
(I2 values of 25%, 50% and 75% corresponded to
cut-off points of low, moderate and high degrees
of heterogeneity, respectively).18 For the primary
and subgroup analyses, we calculated pooled rel-
ative risk (RR) estimates and 95% confidence
intervals (CIs) using random-effects models,
with each study weighted according to inverse of
variance. In a number of trials, some participants
were lost to follow-up or were excluded from
analyses for other reasons; we therefore used
intention-to-treat denominators in the meta-
analyses. In the subgroup meta-analyses, we
investigated whether risk of cesarean delivery
differed according to indication for labour induc-
tion, induction method, gestational age (term,
preterm or post-term), definition of induction
(cervical priming, induction of uterine contrac-
tions or both), cervical status (unfavourable or
favourable), pregnancy risk (high or low) and
parity (nulliparous or parous). 
We used meta-regression analysis to explore
whether patient characteristics (indication for
induction, gestational age at induction, cervical
score, pregnancy risk, parity), induction methods
(type of intervention and definition of induction
[cervical priming v. no cervical priming]) and
study quality (random sequence generation, allo-
cation concealment, performance bias and attri-
tion bias) explained the heterogeneity. We also
evaluated safety (in terms of maternal and fetal
deaths, and admission to neonatal intensive care
unit) and methods of induction currently used in
clinical practice in the United Kingdom, Canada
and the United States.1,2,19 We used the Harbord
modified test for small-study effects to examine
publication bias in funnel plots.
We used Review Manager software (RevMan
version 5.2; Nordic Cochrane Centre, Cochrane
Collaboration, 2012) to conduct the meta-analy-
ses and Stata software (Stata Statistical Software,
release 11; StataCorp; 2009) to perform the
meta-regression analyses.
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Results
We identified 2894 potentially relevant studies
through the literature search. The selection of tri-
als for our meta-analysis is summarized in Fig-
ure 1. After the screening of titles and abstracts
and removal of duplicate records, 215 articles
were reviewed in full. We excluded 58 because
they did not report rates of cesarean delivery
(5 trials), the active intervention was applied in
the control group (10) or within 12 hours after
randomization (3), an incorrect allocation meth -
od was used (8), the control group included
women in spontaneous labour (11), the study
had a nonrandomized design (11), women in
active labour were included at the time of ran-
domization (9), or the trial included women with
a multiple pregnancy (1). The excluded studies,
with reason for exclusion, are listed in Appendix
2 (available at www.cmaj.ca/lookup/suppl
/doi:10.1503/cmaj .130925 /-/DC1).
Characteristics of the 157 RCTs (n = 31 085)
included in the meta-analysis are summarized in
Appendix 3 (available at www.cmaj.ca/lookup
/suppl/doi:10.1503/cmaj.130925 /-/DC1). Despite
extensive searches, we were unable to retrieve
the reports of 4 trials; we extracted available
clinical results for the trials from the Cochrane
Database of Systematic Reviews20–23 but did not
have access to data about the study design to
assess their methodologic quality. The results of
the quality assessment for the other RCTs are
summarized in Figure 2 and shown for each trial
in Appendix 4 (available at www.cmaj.ca/lookup
/suppl/doi:10.1503/cmaj.130925/-/DC1).
The summary results of the primary and sub-
group meta-analyses are shown in Figure 3.
Results for the individual trials are shown in
Appendix 5 (available at www.cmaj.ca/lookup
/suppl/doi:10.1503 /cmaj.130925/-/DC1). Over-
all, the risk of cesarean delivery was lower with
labour induction than with expectant manage-
ment (pooled RR 0.88, 95% CI 0.84–0.93). Sta-
tistical heterogeneity was low (I2 = 0%). Never-
theless, planned meta-regression analysis to
explain heterogeneity did not show a significant
impact of variables on the main result (Appendix
6, available at www.cmaj.ca/lookup/suppl
/doi:10.1503 /cmaj.130925/-/DC1). In particular,
initial cervical score (p = 0.4), indication for
induction (p = 0.8) and method of induction (p =
0.6) did not alter the main result. The test for
publication bias was not significant (p = 0.5)
(Appendix 7, available at www.cmaj.ca/lookup
/suppl/doi:10.1503 /cmaj.130925/-/DC1).
In the subgroup analysis by method of induc-
tion (Figure 3), 4 methods were associated with
a significant reduction in risk of cesarean deliv-
ery: prostaglandin E2 (RR 0.90, 95% CI 0.84–
0.96; I2 = 0%), misoprostol (RR 0.62, 95% CI
0.48–0.81; I2 = 0%), alternative method (RR
0.66, 95% CI 0.50–0.86; I2 = 60.7%) and mixed
method (RR 0.81, 95% CI 0.70–0.95; I2 = 0%).
Subgroup analysis by indication for induction
showed a universal reduction in risk of cesarean
delivery. Induction without a medical indication
provided was associated with risk reduction of
19% (RR 0.81, 95% CI 0.70–0.93; I2 = 13.5%).
When we looked at risk of cesarean delivery by
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Included in meta-analysis
n = 157
Trials reviewed in full
n = 215
Excluded  n = 58
• Did not report rates of cesarean delivery  n = 5
• Used incorrect allocation method  n = 8
• Used active intervention in control group  n = 10
• Used active intervention in control group < 12 h 
after randomization  n = 3
• Control group included women in spontaneous 
labour  n = 11
• Nonrandomized design  n = 11
• Included women in active labour  n = 9
• Included women with multiple pregnancy  n = 1
Excluded  n = 2679
Potentially eligible trials identi!ed 
through literature search
n = 2894
• CAB Abstracts  n = 63 
• Cochrane trials database  n = 111
• Embase n = 1137
• MEDLINE  n =  1341
• Cochrane reviews database  n = 242
Figure 1: Selection of randomized controlled trials for the meta-analysis.
Random sequence generation
(selection bias)
Allocation concealment
(selection bias)
Blinding of participants and 
personnel (performance bias)
Incomplete outcome data
(attrition bias)
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Low risk of bias Unclear risk High risk Not applicable
Figure 2: Risk-of-bias assessment of trials included in the meta-analysis. Results
for individual trials are shown in Appendix 4 (available at www.cmaj.ca/lookup
/suppl/doi:10.1503/cmaj.130925/-/DC1).
gestational age, we found statistically significant
reductions in risk with labour induction in term
and post-term pregnancies, but not in preterm
pregnancies. In the analysis by definition of
induction, risk of cesarean delivery was signifi-
cantly lower when the definition included cervi-
cal ripening alone or combined with stimulation
of uterine contractions than when it included
uterine stimulation alone. The analysis by cervi-
cal status showed a 13% reduction in risk of
cesarean delivery if the cervix was unfavourable
at induction (RR 0.87, 95% CI 0.81–0.94; I2 =
1.4%) and no difference in risk if the cervix was
favourable (RR 0.83, 95% CI 0.60–1.14; I2 =
0%). The risk of cesarean delivery was reduced
in both high- and low-risk pregnancies.
Results from studies with low risk of bias
related to allocation concealment were compati-
ble with the main finding (RR 0.89, 95% CI
0.80–0.99, I2 = 9%). Exclusion of induction
methods not currently used in clinical practice in
the UK, Canada and the US (relaxin, isosorbide
mononitrate, mifepristone, cortico steroids and
alternative methods described earlier in the meth-
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Overall
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Pregnancy risk
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Method of induction
Post-dates pregnancy†
Rupture of membranes before labour
Mixed (fetal, maternal, obstetric)
No medical indication
Indication for induction
Post-term (≥ 42 wk)
Term (37–< 42 wk)
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De!nition of induction
Amniotomy and oxytocin 
Alternative method*
Mechanical
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Prostaglandin  E2
Oxytocin 
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Isosorbide mononitrate
Membrane sweep
Relaxin
Induction of uterine contractions
Parous
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Relative risk (95% CI)
0.84 (0.75–0.94)
0.89 (0.84–0.94)
1.01 (0.75–1.35)
0.93 (0.64–1.34)
0.79 (0.42–1.50)
0.90 (0.74–1.10)
0.96 (0.72–1.29)
0.90 (0.84–0.96)
0.81 (0.70–0.95)
1.03 (0.81–1.31)
0.66 (0.50–0.86)
1.03 (0.83–1.28)
0.62 (0.48–0.81)
I2 value, % 
0.0
60.7
0.0
0.0
10.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
6.9
0.0
0.88 (0.80–0.96)
0.81 (0.70–0.93)
0.87 (0.81–0.95)
0.95 (0.84–1.07)
13.5
0.0
0.0
0.0
1.00 (0.88–1.14)
0.82 (0.69–0.99)
0.87 (0.82–0.92) 0.0
0.7
0.0
0.87 (0.81–0.94)
0.83 (0.60–1.14) 0.0
1.4
1.01 (0.85–1.19)
0.71 (0.58–0.86)
0.88 (0.84–0.93)
2.3
0.0
0.0
No. of trials
15
8
11
4
6
17
3
4
4
67
17
103
54
157
33
34
60
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113
26
14
7
98
17
22
118
0.94 (0.77–1.13)
0.97 (0.81–1.17) 0.0
9.2
16
7
11.0 10
Decreased 
risk
Increased 
risk
Relative risk (95% CI)
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Figure 3: Overall and subgroup analyses investigating the effect of induction of labour versus expectant management on the risk of
cesarean delivery. Values less than 1 indicate a decreased risk of cesarean delivery. *Acupuncture, breast stimulation, sexual inter-
course, homeopathic preparations, castor oil, bath or enema. †Gestation > 40 wk. CI = confidence interval.
ods) showed an effect comparable to the main
result (RR 0.89, 95% CI 0.84–0.93; I2 = 0%). 
Analysis of adverse outcomes showed a lower
risk of fetal death and admission to neonatal
intensive care unit associated with labour induc-
tion than with expectant management (Table 1).
No impact on maternal death was shown.
Interpretation
Our meta-analysis showed that the risk of
cesarean delivery following labour induction was
significantly lower than the risk associated with
expectant management. This finding supports
evidence from systematic reviews5–8 but is con-
trary to prevalent beliefs and information from
consumer organizations, guidelines and text-
books.10–13 Labour induction was associated with
benefits for the fetus and no increased risk of
maternal death.
Subgroup analysis by method of induction
showed a significant reduction in risk of
cesarean delivery associated with the use of
prostaglandin E analogues (prostaglandin E2
and misoprostol). This is encouraging, since use
of prostaglandin E2 is the main method of
induction in the UK and the main method of
cervical ripening in the US and Canada.1,2,19
However, use of oxytocin and amniotomy, still
widely practised induction methods, did not
confer a benefit on cesarean delivery. In the sub-
group analysis by indication for induction,
mixed reason (maternal, fetal and obstetric) and
post-dates pregnancy were associated with a
reduced risk of cesarean delivery. In uncompli-
cated term pregnancies with no medical reason
for induction provided, the risk of cesarean
delivery was reduced by 19% on average. We
also observed risk reductions associated with
induction in term and post-term pregnancies and
in high- and low-risk pregnancies. Our findings
are important when selecting candidates for
labour induction and when advising women on
the risks of induction.
Limitations
Our study has limitations. We could not retrieve
and verify 4 primary studies and therefore had to
use numeric data obtained from the Cochrane
Database of Systematic Reviews. However, the
reliance on these data likely did not have much
effect on the results because our analysis includ-
ing the remaining 153 studies was sufficiently
powerful for reliable inferences. When we
updated our searches in February 2014, we
found 336 new citations published since April
2012. Of these, only 2 trials24,25 met our inclusion
criteria. The number of participants in the trials
was 636, which represented 2% of the total in
our current analysis. Both studies concluded that
there was no effect on cesarean delivery rates
with relative imprecision, so our main conclu-
sion remains robust.
We restricted our analyses to RCTs with appro-
priate sequence generation, minimizing the risk of
bias and confounding. Concealment of allocation
was reported unclearly in half of the studies, risk-
ing bias in both the clinical management of the
women and the assessment of outcomes. However,
studies with a low risk of bias in allocation con-
cealment supported the main finding.
We explored many potential confounding fac-
tors but did not account for all. For example,
body mass index and maternal age may be asso-
ciated with increased rates of complication. We
could not always disentangle reasons for induc-
tion and had to lump together maternal, fetal and
obstetric indications, leading to some difficulty
in interpretation.
We included studies dating from 1975 to
2010; therefore, differences in practice over this
period may have influenced the findings. These
issues would be best addressed in a meta-analy-
sis of individual patient data. 
Although 2 of us abstracted the study data
independently, errors in coding may have
occurred and thus are a potential source of bias.
This is especially true for the definition of
induction and assessment of pregnancy risk,
because these parameters were not always
defined in detail in the primary studies and had
to be judged.
Conclusion
Our meta-analysis has provided a robust answer
to the disputed question of risk of cesarean deliv-
ery associated with induction of labour. Women
whose labour was induced were less likely than
those managed expectantly to have a cesarean
delivery. In addition, the risk of fetal death and
admission to neonatal intensive care unit were
decreased in the induction group. Our findings
have implications for guidelines and the practice
of obstetrics, and are reassuring for mothers,
midwifes and obstetricians.
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Table 1: Risk of adverse outcomes associated with labour induction versus 
expectant management 
Outcome Relative risk (95% CI) I2 value, % No. of trials 
Fetal death 0.50 (0.25–0.99) 0 60 
Admission to NICU 0.86 (0.79–0.94) 0 55 
Maternal death 1.00 (0.10–9.57) 0 20 
Note: CI = con!dence interval, NICU = neonatal intensive care unit. 
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